126 related articles for article (PubMed ID: 21641951)
41. The effect of azithromycin on the immunogenicity of oral poliovirus vaccine: a double-blind randomised placebo-controlled trial in seronegative Indian infants.
Grassly NC; Praharaj I; Babji S; Kaliappan SP; Giri S; Venugopal S; Parker EP; Abraham A; Muliyil J; Doss S; Raman U; Liu J; Peter JV; Paranjape M; Jeyapaul S; Balakumar S; Ravikumar J; Srinivasan R; Bahl S; Iturriza-Gómara M; Uhlig HH; Houpt ER; John J; Kang G
Lancet Infect Dis; 2016 Aug; 16(8):905-14. PubMed ID: 27156189
[TBL] [Abstract][Full Text] [Related]
42. Fractional doses of inactivated poliovirus vaccine in Oman.
Mohammed AJ; AlAwaidy S; Bawikar S; Kurup PJ; Elamir E; Shaban MM; Sharif SM; van der Avoort HG; Pallansch MA; Malankar P; Burton A; Sreevatsava M; Sutter RW
N Engl J Med; 2010 Jun; 362(25):2351-9. PubMed ID: 20573923
[TBL] [Abstract][Full Text] [Related]
43. Progress toward interruption of wild poliovirus transmission--worldwide, January 2006-May 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(27):682-5. PubMed ID: 17625496
[TBL] [Abstract][Full Text] [Related]
44. Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary.
Estívariz CF; Molnár Z; Venczel L; Kapusinszky B; Zingeser JA; Lipskaya GY; Kew OM; Berencsi G; Csohán A
Am J Epidemiol; 2011 Aug; 174(3):316-25. PubMed ID: 21685412
[TBL] [Abstract][Full Text] [Related]
45. Progress toward interruption of wild poliovirus transmission--worldwide, January 2007-April 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 May; 57(18):489-94. PubMed ID: 18463607
[TBL] [Abstract][Full Text] [Related]
46. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines.
Bull World Health Organ; 1996; 74(3):253-68. PubMed ID: 8789924
[TBL] [Abstract][Full Text] [Related]
47. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children.
Breiman RF; Brooks WA; Goswami D; Lagos R; Borja-Tabora C; Lanata CF; Londoño JA; Lum LC; Rappaport R; Razmpour A; Walker RE; Gruber WC; Forrest BD
Vaccine; 2009 Sep; 27(40):5472-9. PubMed ID: 19616493
[TBL] [Abstract][Full Text] [Related]
48. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
[TBL] [Abstract][Full Text] [Related]
49. Progress toward poliomyelitis eradication--India, January 2005-June 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Jul; 55(28):772-6. PubMed ID: 16855526
[TBL] [Abstract][Full Text] [Related]
50. Progress toward poliomyelitis eradication--Pakistan and Afghanistan, January 2005-May 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Jun; 55(24):679-82. PubMed ID: 16791135
[TBL] [Abstract][Full Text] [Related]
51. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
Chowdhary R; Dhole TN
J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
[TBL] [Abstract][Full Text] [Related]
52. The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal.
Cardemil CV; Estivariz C; Shrestha L; Sherchand JB; Sharma A; Gary HE; Oberste MS; Weldon WC; Bowen MD; Vinjé J; Schluter WW; Anand A; Mach O; Chu SY
Vaccine; 2016 May; 34(22):2519-26. PubMed ID: 27085172
[TBL] [Abstract][Full Text] [Related]
53. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India.
Grassly NC; Jafari H; Bahl S; Durrani S; Wenger J; Sutter RW; Aylward RB
J Infect Dis; 2009 Sep; 200(5):794-801. PubMed ID: 19624278
[TBL] [Abstract][Full Text] [Related]
54. Effect of breast-feeding on seroresponse of infants to oral poliovirus vaccination.
John TJ; Devarajan LV; Luther L; Vijayarathnam P
Pediatrics; 1976 Jan; 57(1):47-53. PubMed ID: 174056
[TBL] [Abstract][Full Text] [Related]
55. Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh.
Emperador DM; Velasquez DE; Estivariz CF; Lopman B; Jiang B; Parashar U; Anand A; Zaman K
Clin Infect Dis; 2016 Jan; 62(2):150-6. PubMed ID: 26349548
[TBL] [Abstract][Full Text] [Related]
56. Progress toward poliomyelitis eradication--Nigeria, January 2007-August 12, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Aug; 57(34):942-6. PubMed ID: 18756194
[TBL] [Abstract][Full Text] [Related]
57. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
58. Effect of administration of 200,000 IU of vitamin A to women within 24 hrs after delivery on response to PPV administered to the newborn.
Bhaskaram P; Balakrishna N
Indian Pediatr; 1998 Mar; 35(3):217-22. PubMed ID: 9707874
[TBL] [Abstract][Full Text] [Related]
59. 2001 serological survey in the Czech Republic--poliomyelitis.
Matyásová I; Rainetová P; Cástková J
Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
[TBL] [Abstract][Full Text] [Related]
60. Role of genetic factors in polio eradication: new challenge for policy makers.
Paul Y
Vaccine; 2007 Dec; 25(50):8365-71. PubMed ID: 17996995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
